Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Pfau

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Die Ophthalmologie|May 28, 2025
[Pseudoxanthoma elasticum-Novel therapeutic approaches on the horizon?]Jonathan Meinke, Kristin Raming, Maximilian Pfau, et al.
Clinical & Experimental Ophthalmology|April 18, 2017
Persistent visual loss in dengue fever due to outer retinal damagePetra P Fang, Maximilian Pfau, Frank G Holz, et al.
American Journal of Ophthalmology|April 13, 2024
Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual OutcomeKristin Raming, Maximilian Pfau, Philipp Herrmann, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 12, 2019
[Dry Age-Related Macular Degeneration - Epidemiology and Classification]Monika Fleckenstein, Sarah Thiele, Maximilian Pfau, et al.
Retina (Philadelphia, Pa.)|January 22, 2025
DRUSEN VOLUME AS CLINICAL OUTCOME MEASURE IN SUBJECTS WITH MALATTIA LEVENTINESEClara Ehrenzeller, Giuseppe Cancian, Arianna Paris, et al.
Eye (London, England)|October 30, 2024
Age-related macular degeneration: natural history revisited in geographic atrophyEliza Broadbent, Sandrine H Künzel, Maximilian Pfau, et al.
Acta Ophthalmologica|November 24, 2024
Test-retest variability of mesopic microperimetry-associated parameters in patients with retinitis pigmentosa: REPEAT Study Report No. 2Jessica S Karuntu, Maximilian Pfau, Jasleen K Jolly, et al.
Ophthalmic Research|September 29, 2015
Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusionMaximilian Pfau, Heidi Fassnacht-Riederle, Matthias D Becker, et al.
Investigative Ophthalmology & Visual Science|February 22, 2023
Choriocapillaris Flow Signal Impairment in Patients With Pseudoxanthoma ElasticumAnne-Sophie Loewinger, Maximilian Pfau, Philipp Herrmann, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 11, 2020
Optical Coherence Tomography-Angiography in Geographic AtrophyPhilipp L Müller, Maximilian Pfau, Steffen Schmitz-Valckenberg, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Die Ophthalmologie|May 28, 2025
[Pseudoxanthoma elasticum-Novel therapeutic approaches on the horizon?]Jonathan Meinke, Kristin Raming, Maximilian Pfau, et al.
Clinical & Experimental Ophthalmology|April 18, 2017
Persistent visual loss in dengue fever due to outer retinal damagePetra P Fang, Maximilian Pfau, Frank G Holz, et al.
American Journal of Ophthalmology|April 13, 2024
Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual OutcomeKristin Raming, Maximilian Pfau, Philipp Herrmann, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 12, 2019
[Dry Age-Related Macular Degeneration - Epidemiology and Classification]Monika Fleckenstein, Sarah Thiele, Maximilian Pfau, et al.
Retina (Philadelphia, Pa.)|January 22, 2025
DRUSEN VOLUME AS CLINICAL OUTCOME MEASURE IN SUBJECTS WITH MALATTIA LEVENTINESEClara Ehrenzeller, Giuseppe Cancian, Arianna Paris, et al.
Eye (London, England)|October 30, 2024
Age-related macular degeneration: natural history revisited in geographic atrophyEliza Broadbent, Sandrine H Künzel, Maximilian Pfau, et al.
Acta Ophthalmologica|November 24, 2024
Test-retest variability of mesopic microperimetry-associated parameters in patients with retinitis pigmentosa: REPEAT Study Report No. 2Jessica S Karuntu, Maximilian Pfau, Jasleen K Jolly, et al.
Ophthalmic Research|September 29, 2015
Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusionMaximilian Pfau, Heidi Fassnacht-Riederle, Matthias D Becker, et al.
Investigative Ophthalmology & Visual Science|February 22, 2023
Choriocapillaris Flow Signal Impairment in Patients With Pseudoxanthoma ElasticumAnne-Sophie Loewinger, Maximilian Pfau, Philipp Herrmann, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 11, 2020
Optical Coherence Tomography-Angiography in Geographic AtrophyPhilipp L Müller, Maximilian Pfau, Steffen Schmitz-Valckenberg, et al.
Pageof 16